We’re excited to announce our collaboration with the University of Oxford in the field of AI for the evaluation of Barrett’s Oesophagus and Oesophageal Cancer. Learn more about the collaboration: bit.ly/3LIro3j

We can't wait to see you at UEG 2023! Make sure to reach out to Dr. Michael Byrne, Solveig Johannessen, Ben Brzezynski, Dr. Nasim Parsa, and Russell Cabeliza if you’d like to meet the team! See you soon! 🇩🇰 my_UEG

Alimentiv and Satisfai Health Announce the Commercial Availability of a Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials. Click the link to access the full press release: bit.ly/3RL9CjA

Dr. Michael Byrne moderating the AI in lower GI endoscopy with Dr. Yuichi Mori at UEG - United European Gastroenterology! my_UEG

Dr. Michael Byrne and Dr. Alanna Ebigbo moderating the UEG Abstract Session - AI in lower GI endoscopy. Lots of insightful presentations today! my_UEG

Team Satisfai Health Inc at UEG week! #UEGWeek2023 #UEGWeek #GITwitter Nasim Parsa, M.D. Michael Byrne my_UEG UEG Week

Some words from Michael Byrne about UEG Week and his upcoming debate with Dr. Yuichi Mori! #UEGWeek2023 #GITwitter my_UEG UEG Week

UEG was a success! And to top it all off, our Barrett’s Esophagus Optical Biopsy software, Veritai*, took centre stage during a live endoscopy procedure on the last day of UEG week! *currently available for investigational use only. Nasim Parsa, M.D. my_UEG #UEGWeek2023 #UEGWeek

🚨Come see some of our latest work @ #ACG2023 We demonstrate feasibility of automated & accurate recording of cecal intubation, tool usage & withdrawal duration using #AI MachineLearning has the potential to serve as a transformative documentation tool for video guided procedures

November marks Crohn’s & Colitis Awareness Month in Canada. Join us as we embrace this year's theme of knowledge and education. Together, we can build understanding, empathy, and support. Learn more about the Awareness Month 2023 celebration in Canada: bit.ly/49vViSO

Same issue exists for #AI & #endoscopy Lack of reimbursement will stifle adoption & patient benefit But we need the health economic data to go with clinical effectiveness & ideally save administrative costs as well Great read on AI & healthcare economics👇 nature.com/articles/s4174…

"The machine sees things that the human eye cannot see, or even conceive of." For our latest #StoriesOfDiscovery, we speak to Dr Mike Byrne Satisfai Health Inc about AI tools to detect colon cancer, oesophageal cancer and inflammatory bowel disease. 🗞️Read: tinyurl.com/54dtvkrs

Next guest on UCD Human Health, Impact and Technology series (#HHITseries) is Dr Mike Byrne Satisfai Health Inc who will speak to host Professor Patricia Maguire about using AI to detect colon cancer and IBD. Tues, Nov 21, 4pm-4:15pm (Irish time) All welcome! Register: ucd-ie.zoom.us/webinar/regist…

This World Pancreatic Cancer Day, let's reintroduce ourselves to this small but mighty organ. Say “Hello Pancreas” with us and join the global movement to raise awareness. Knowledge is power, and together, we can make a difference. 💜 #WPCD #HelloPancreas

Our #HHITseries webinar with Dr Mike Byrne at Satisfai Health Inc has just kicked off, with host Professor Patricia Maguire. Mike explains how #ai is helping physicians detect cancerous polyps in the GI tract to reduce incidence of colon cancer, oesophageal cancer and inflammatory bowel disease.

Happy Thanksgiving from the Satisfai Team! Wishing you and your families all the best of this season!

Happy New Year from Satisfai Health! Our team returned from the break energized and excited for great achievements in 2024 ⭐️🎆❄️

Next up in our calendar is the 19th Annual Congress of the European Crohns and Colitis Organisation (ECCO) in Stockholm, from February 21-24. Our team will be showcasing innovative AI technologies for the digital assessment and scoring of IBD. #ECCO24

We are thrilled to announce the appointment of Solveig Johannessen as our new CEO! Solveig succeeds our founder, Dr. Michael Byrne, who will continue as Executive Chairman and CMO. Full announcement: thenewswire.com/press-releases…

Going to #ECCO this year? Here's a quick write-up in Pharma Technology Focus on the state of IBD drug development. Catch up with Michael Byrne and Ben Brzezynski in Stockholm to learn how AI will impact measurement in trials and drug development. pharmaceutical-technology.com/features/how-p…